Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis

Table 3 Summary of studies included in the pooled analyses of transjugular intrahepatic portosystemic shunt in patients with refractory hepatic hydrothorax

Ref.	No. of patients	Complete response (%)	Partial response (%)	45-d mortality (%)	1-yr survival (%)	Predictors of mortality
Gordon et al[14]	24	58	21	21	NA	TIPSS nonresponse
						CTP class C
Jeffries et al[24]	12	42	17	25	NA	Age > 65 yr
Siegerstetter et al[26]	40	53	28	13	64	Age > 60 yr
Spencer et al[27]	21	57	10	29	NA	Medical comorbidities
Wilputte et al[28]	28	57	11	14	41	CTP score > 10
						Mayo score > 1.5
Dhanasekaran	73	59	21	19	48	MELD > 15
et al[23]						Nonresponse
						Elevated creatinine

CTP: Child-Turcotte-Pugh; MELD: Model for end-stage liver disease; NA: Not applicable; TIPSS: Transjugular intrahepatic portosystemic stent shunt.